Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
- DOI
- 10.1038/s41591-024-03235-9
- Published
- 2024-09-23
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-024-03235-9,
title = {Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial},
author = {Scott Kopetz and Danielle A. Murphy and Jie Pu and Fortunato Ciardiello and Jayesh Desai and Eric Van Cutsem and Harpreet Singh Wasan and Takayuki Yoshino and Hedieh Saffari and Xiaosong Zhang and Phineas Hamilton and Tao Xie and Rona Yaeger and Josep Tabernero},
year = {2024},
journal = {Nature Medicine},
doi = {10.1038/s41591-024-03235-9},
url = {https://doi.org/10.1038/s41591-024-03235-9}
}RIS
TY - JOUR TI - Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial AU - Scott Kopetz AU - Danielle A. Murphy AU - Jie Pu AU - Fortunato Ciardiello AU - Jayesh Desai AU - Eric Van Cutsem AU - Harpreet Singh Wasan AU - Takayuki Yoshino AU - Hedieh Saffari AU - Xiaosong Zhang AU - Phineas Hamilton AU - Tao Xie AU - Rona Yaeger AU - Josep Tabernero PY - 2024 JO - Nature Medicine DO - 10.1038/s41591-024-03235-9 UR - https://doi.org/10.1038/s41591-024-03235-9 ER -
APA
Kopetz, S., Murphy, D. A., Pu, J., Ciardiello, F., Desai, J., Cutsem, E. V., Wasan, H. S., Yoshino, T., Saffari, H., Zhang, X., Hamilton, P., Xie, T., Yaeger, R., & Tabernero, J. (2024). Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial. Nature Medicine. https://doi.org/10.1038/s41591-024-03235-9
Source records
- crossref · retrieved 2026-09-26T15:50:45.825Z